MedTrace Logo

Carotid Plaque Screening Trial in Smokers

NCT00548665 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 536

Last updated 2014-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine the impact of carotid plaque screening on smoking cessation and control of other cardiovascular risk factors.

Conditions

  • Smoking

Interventions

DEVICE

Carotid ultrasound for plaque screening

Carotid ultrasound for plaque screening

BEHAVIORAL

Brief advice for smoking cessation

We will use the 5A's heuristic (Ask about smoking, Advise on cessation, Assess willingness to change, and for those willing to make quit attempt: Assist with attempt to quit, and Arrange for follow-up) and the gold standard for brief smoking cessation advice. At each visit, smokers will receive smoking cessation counseling and nicotine replacement therapy, similar to the experimental group.

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • Swiss Heart Foundation

    collaborator OTHER

  • Swiss Tobacco Prevention Funds

    collaborator UNKNOWN

  • University of Lausanne

    lead OTHER

Principal Investigators

  • Nicolas Rodondi, MD, MAS · University of Lausanne, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-12-31
Completion
2012-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548665 on ClinicalTrials.gov